Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement

European Journal of Endocrinology

Volumn 140, Issue 2, 1999, Pages 174-179

  Leese, G P ^a   Wallymahmed, M ^b   Wieringa, G ^c   VanHeyningen, C ^b   MacFarlane, I A ^b  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b Walton Hospital   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT GROWTH HORMONE; TRIACYLGLYCEROL;

ADULT; ALLELISM; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BLOOD LEVEL; MALE; PHENOTYPE; PRIORITY JOURNAL; ERRATUM; ERROR;

ADULT; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLESTEROL, HDL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; LIPIDS; MALE; PHENOTYPE; RECOMBINANT PROTEINS;

EID: 0033036095     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400174     Document Type: Article

References (33)

1. Cuneo RC, Salomon F, Watts GF, Hesp R & Sonsken PH. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 1993 42 1519-1523.
2. deBoer H. Blok GJ, Voerman HJ, Philips M & Schouten JA. Serum lipids in growth hormone deficient men. Metabolism 1994 43 199-205.
3. Beshayh SA, Henderson A, Niththyananthan R, Skinner E, Anyaoku V, Richmond W et al. The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism 1995 80 356-363.
4. Binnerts A, Roel Stewart G, Paul Wilson JH, Hoogerbrugge N, Pols HAP, Birkenhager JC et al. The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clinical Endocrinology 1992 37 79-87.
5. Salomon F, Cuneo RC, Hesp R & Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803.
6. Eden S, Wiklund O, Oscarsson J, Rosen T & Bengtsson B-A. Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp(a) and HPL-cholesterol concentrations. Arteriolsclerosis Thrombosis 1993 15 296-301.
7. Russell-Jones DL, Watts GF, Weissberger A, Naoumova R, Myers J, Thompson GR et al. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clinical Endocrinology 1994 41 545-550.
8. Garry P, Collins P & Devlin JG. An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. European Journal of Endocrinology 1996 134 61-66.
9. Asayama K, Amemiya S, Kusano S & Kato K. Growth hormone induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism 1984 33 129-131.
10. Blackett PR, Weech PK, McConathy WJ & Fesmire JD. Growth hormone in the regulation of hyperlipidaemia. Metabolism 1982 31 117-120.
11. Leese GP, Wallymahmed M, Van Heyningen C, Tames F & MacFarlane IA. HDL-cholesterol reductions associated with adult growth hormone. Clinical Endocrinology 1998 49 675-678.
12. Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC, Valk NK et al. Adult growth hormone deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during growth hormone treatment. Journal of Clinical Endocrinology and Metabolism 1997 82 82-88.
13. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S et al. The Australian multicenter trial of growth hormone (GH) treatment in GH-deticient adults. Journal of Clinical Endocrinology and Metabolism 1998 83 107-116.
14. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA et al. Familial apolipoprotein E deficiency. Journal of Clinical Investigation 1986 78 1206-1219.
15. Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RHT & MacFarlane IA. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clinical Endocrinology 1997 47 439-446.
16. Friedwald WT, Levy RL & Fredrickson DS, Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
17. Kane JW & Gowland E. A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Annals of Clinical Biochemistry 1986 25 509-515.
18. McDowell IFW, Brian Wisdom G & Trimble ER. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clinical Chemistry 1988 25 638-644.
19. Oscarsson J, Ottosson M, Wiklund O, Marin P, Vikman-Adolfsson, BJorntorp P et al. Low dose continuously infused growth hormone results in increased lipoprotein (a) and decreased low density lipoprotein cholesterol concentrations in middle aged men. Clinical Endocrinology 1994 41 109-116.
20. O'Halloran DJO, Wieringa G, Tsatsoulis A & Shalet S. Increased serum lipoprotein (a) concentrations after growth hormone treatment in patients with isolated growth hormone deficiency. Annals of Clinical Biochemistry 1996 33 330-334.
21. Davignon J, Gregg RE & Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis Thrombosis 1988 8 1-21.
22. Manttari M, Koskinen P, Ehnholm C, Huttunen & Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991 40 217-221.
23. Zambon D, Ros E, Casals E, Sanllehy C, Bertomeu A & Campero I. Effect of lipoprotein E polymorphism on the serum lipid response to a hypolipidaemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. American Journal of Clinical Nutrition 1995 61 141-148.
24. Kamboh MI, Aston CE, Ferrell RE & Hamman RF. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis 1993 98 201-211.
25. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM & Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arteriosclerosis Thrombosis 1991 11 1100-1110.
26. Elan MB, Simkevich CP, Solomon SS, Wilcox HG, & Heinberg M. Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. Endocrinology 1988 122 1397-1402.
27. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson J-A & Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proceedings of the National Academy of Sciences of the USA 1992 89 6983-6987.
28. Johannsson G, Oscarsson J, Rosen T, Wiklund O, Olssen G, Wilhelmsen L et al. Effect of 1 year growth hormone therapy on serum lipoprotein (a) levels in growth hormone deficient adults. Influence of gender and apo(a) and apo E phenotype. Arteriosclerosis. Thrombosis and Vascular Biology 1995 15 2142-2150.
29. White RM, Schaefer EJ & Papodopoulos NM. The effect of growth hormone administration on lipids and lipoproteins in growth hormone deficient patients. Proceedings of the Society for Experimental Biology and Medicine 1983 173 63-67.
30. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ. Maguire G et al. Cholesterol ester transfer protein and high density Iipoprotcin responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. Journal of Lipid Research 1993 34 437-446.
31. Tall AR. Plasma cholesterol ester transfer protein. Journal of Lipid Research 1993 34 1255-1274.
32. deKnijff P, Kaptein A & Boomsma D. Apolipoprotein E, polymorphism affects plasma levels of lipoprotein (a). Atherosclerosis 1991 90 169-174.
33. Mackness MI, Bhatnagar D, Wieringa G, Tsatsoulis A & Shalet S. A comparative study of six commercial lipoprotein (a) assays in seventeen laboratories within the British Isles. Annals of Clinical Biochemistry 1996 33 63-70.